Growth/differentiation factor 5 and glial cell line-derived neurotrpphic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease

European Journal of Neuroscience

Volumn 10, Issue 12, 1998, Pages 3681-3688

  Sullivan, Aideen M ^a,c   Pohl, Jens ^b   Blunt, Stavia B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Biopharm GmbH   (Germany)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

6 hydroxydopamine; Neural transplantation; Neuroprotection; Position emission tomography

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; NEUROTROPHIN; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MALE; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BONE MORPHOGENETIC PROTEINS; BRAIN TISSUE TRANSPLANTATION; CELL COUNT; CELL SURVIVAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; GROWTH SUBSTANCES; IMMUNOHISTOCHEMISTRY; MALE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; TOMOGRAPHY, EMISSION-COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TYROSINE 3-MONOOXYGENASE;

EID: 0032457981     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00378.x     Document Type: Article

References (44)

1. Abercrombie, M. (1946) Estimation of nuclear population from microtome sections. Anat. Rec., 94, 239-247.
2. Ahlskog, J.E. (1993) Cerebral transplantation for Parkinson's disease: current progress and future prospects. Mayo Clin. Proc., 68, 578-591.
3. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A. & Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature, 373, 339-341.
4. Bjorklund, A. (1993) Better cells for brain repair. Nature, 362, 414-415.
5. Bjorklund, A., Stenevi, U., Schmidt, R.H., Dunnett, S.B. & Gage, F.H. (1983) Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand., S522, 1-7.
6. Bloomfield, P.M., Myers, R., Hume, S.P., Spinks, T.J., Lammertsma, A.A. & Jones, T. (1997) Three-dimensional performance of a small-diameter positron emission tomograph. Phys. Med. Biol., 42, 389-400.
7. Bloomfield, P.M., Rajeswaran, S., Spinks, T.J., Hume, S.P., Myers, R., Ashworth, S., Clifford, K.M., Jones, W.F., Byars, L.G., Young, J., Andreaco, M., Williams, C.W., Lammertsma, A.M. & Jones, T. (1995) The design and physical characteristics of a small animal positron emission tomograph. Phys. Med. Biol., 40, 1105-1126.
8. Brundin, P., Isacson, O. & Bjorklund, A. (1985) Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res., 331, 251-259.
9. Brundin, P., Strecker, R.E., Widner, H., Clarke, D.J., Nilsson, O.G., Astedt, B., Lindvall, O. & Bjorklund, A. (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res., 70, 192-208.
10. Engele, J. & Bohn, M.C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci., 11, 3070-3078.
11. Ferrari, G., Minozzi, M.-C., Toffano, G., Leon, A. & Skaper, S.D. (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol., 133, 140-147.
12. Granholm, A.-C., Molt, J.L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B.J., Lapchak, P.A., Palmer, M.R., van Home, C. & Gerhardt, G.A. (1997) Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res., 116, 29-38.
13. Haque, N.S.K., Hlavin, M.-L., Fawcett, J.W. & Dunnett, S.B. (1996) The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Brain Res., 712, 45-52.
14. Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.-F.H. & Gerhardt, G.A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Letts., 182, 107-111.
15. Hotten, G., Neidhardt, H., Jacobowsky, B. & Pohl, J. (1994) Cloning and expression of recombinant human growth/differentiation factor 5. Biochem. Biophys. Res. Comm., 204, 646-652.
16. 11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Nucl. Med. Biol., 23, 377-384.
17. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, R.G., Luthra, S.J., Brooks, D.J. & Lammertsma, A.A. (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse, 12, 47-54.
18. Hyman, C., Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, G.D., Squinto, S.P. & Lindsay, R.M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature, 350, 230-232.
19. Kearns, C.M. & Gash, D.M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res., 672, 104-111.
20. Knusel, B., Michel, P.P., Schwaber, J.S. & Hefti, F. (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci., 10, 558-570.
21. Krieglstein, K., Suter-Crazzolara, C., Hotten, G., Pohl, J. & Unsicker, K. (1995) Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-β superfamily, on midbrain dopaminergic neurons. J. Neurosci. Res., 42, 724-732.
22. Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S. & Collins, F. (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.
23. Lindvall, O. (1994) Neural transplantation in Parkinson's disease. In Dunnett, S.B. & Bjorklund, A. (eds), Functional Neural Transplantation. Raven Press, New York, pp. 103-137.
24. Mayer, E., Fawcett, J.W. & Dunnett, S.B. (1993) Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons-II. Effects on nigral transplants in vivo. Neuroscience, 56, 389-398.
25. Nakao, N., Frodl, E.M., Widner, H., Carlson, E., Eggerding, F.A., Epstein, C.J. & Brundin, P. (1995) Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med., 1, 226-231.
26. Olanow, C.W., Kordower, J.H. & Freeman, T.B. (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci., 19 102-109.
27. Opacka-Juffry, J., Ashworth, S., Hume, S.P., Martin, D., Brooks, D.J. & Blunt, S.B. (1995) GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. NeuroReport, 7, 348-352.
28. Pellegrino, L.J., Pellegrino, A.S. & Cushman, A.J. (1979) A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York.
29. Poulsen, K.T., Armanini, M.P., Klein, R.D., Hynes, M.A., Phillips, H.S. & Rosenthal, A. (1994) TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron, 13, 1245-1252.
30. Robb, R.A. & Hanson, D.P. (1991) A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas. Phys. Eng. Sci., 14, 9-30.
31. Robinson, T.E. (1984) Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacol., 84, 466-475.
32. Rosenblad, C., Martinez-Serrano, A. & Bjorklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience, 75, 979-985.
33. Sauer, H., Fischer, W., Nikkhah, G., Wiegand, S.J., Brundin, P., Lindsay, R.M. & Bjorklund, A. (1993) Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res., 626, 37-44.
34. Sinclair, S.R., Svendsen, C.N., Torres, E.M., Martin, D., Fawcett, J.W. & Dunnett, S.B. (1996) GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport, 7, 2547-2552.
35. Steinbusch, H.W.M., Vermeulen, R.J. & Tonnaer, J.A.D.M. (1990) Basic fibroblast growth factor enhances the survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: preliminary observations. Prog. Brain Res., 82, 81-86.
36. Storm, E.E., Huynh, T.V., Copeland, N.G., Jenkin, N.A., Kingsley, D.M. & Lee, S.-J. (1994) Limb alterations in bradypodism mice due to mutations in a new member of the TGFβ -superfamily. Nature, 368, 639-643.
37. Sullivan, A.M., Opacka-Juffry, J. & Blunt, S.B. (1998) Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Eur. J. Neurosci., 10, 57-63.
38. Sullivan, A.M., Opacka-Juffry, J., Hotten, G., Pohl, J. & Blunt, S.B. (1997) Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease. Neurosci. Letts., 233, 73-76.
39. Takayama, H., Ray, J., Raymon, H.K., Baird, A., Hogg, J., Fisher, L.J. & Gage, F.H. (1995) Basic dopaminergic growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med., 1, 53-58.
40. Tomac, A., Lindqvist, E., Lin, L.-F.H., Ogren, S.O., Young, D., Hoffer, B.J. & Oison, L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature, 373, 335-339.
41. Ungerstedt, U. & Arbuthnott, G.W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain. Res., 24, 485-493.
42. Wang, Y., Tien, L.T., Lapchak, P.A. & Hoffer, B.J. (1996) GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Cell Tissue Res., 286, 225-233.
43. Yurek, D.M., Lu, W., Hipkens, S. & Wiegand, S.J. (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine cells. Exp. Neurol., 137, 105-118.
44. Zhou, J., Bradford, H.F. & Stern, G.M. (1997) Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants. Dev. Brain Res., 100, 43-51.